Literature DB >> 23134960

[Effects of transcutaneous electrical stimulation of auricular Shenmen point on postoperative nausea and vomiting and patient-controlled epidural analgesia in cesarean section].

Jing-zhu Li1, Xiao-zheng Li, Ming-shan Wang, Jie-ping Li, Fei Shi, Hai-fang Yu.   

Abstract

OBJECTIVE: To investigate the effects of transcutaneous electrical stimulation of auricular Shenmen point on postoperative nausea and vomiting and patient-controlled epidural analgesia in cesarean section.
METHODS: After IRB approval and informed consent, one hundred and eighty singleton primiparas undergoing elective cesarean section, in Qingdao Municipal Hospital, and Qingdao Hiser Medical Center, from November 2011 to March 2012, were randomly assigned to three groups: transcutaneous electrical stimulation of auricular Shenmen point group (group A, n = 60), transcutaneous electrical stimulation of auricular Eye point group (group B, n = 60) and control group (group C, n = 60). Women of group A received transcutaneous electrical stimulation of auricular Shenmen point (frequency 1.5 HZ) at the time of preoperation, 4, 10 and 22 hours of postoperation for 30 minutes. The strength was controlled by themselves. Women of group B received stimulation of auricular Eye point as group A. Women of group C received pressurization and connected line were the same with group A, but without electrical stimulation. The following indexes was observed: the incidence of postoperative nausea and vomiting (PONV) for 48 hours; the rate of metoclopramide; the visual analogue scale (VAS) score of rest pain, uterine contration pain and dynamic pain at the time of postoperation for 6, 12, 24 and 48 hours (T(1)-T(4)); the total number and effective compressions number of patient-controlled epidural analgesia(PCEA);the dose of analgesia mixture; the anal exhaust time; the volume of postoperative bleeding for 6 hours of postoperation and the other side effects.
RESULTS: Compared with group B and group C, the incidence of PONV, the rate of metoclopramide, the VAS score at the time T(1)-T(4), the total number and effective compressions number of PCEA, the ratio of the total number with effective compressions number and the dose of analgesia mixture were decreased in group A (P < 0.05), but no difference compared group B with group C (P > 0.05). The anal exhaust time and the volume of postoperative bleeding for 6 hours of postoperation were no difference in the three groups (P > 0.05). No other side effects were observed.
CONCLUSION: Transcutaneous electrical stimulation of auricular Shenmen point can reduce the incidence of PONV and improves analgesia effect of PCEA in postoperation of cesarean section.

Entities:  

Mesh:

Year:  2012        PMID: 23134960

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  4 in total

1.  Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.

Authors:  James D Griffiths; Gillian Ml Gyte; Phil A Popham; Kacey Williams; Shantini Paranjothy; Hannah K Broughton; Heather C Brown; Jane Thomas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

2.  Comparison of effect of auriculotherapy and mefenamic acid on the severity and systemic symptoms of primary dysmenorrhea: a randomized clinical trial.

Authors:  Masoomeh Vahedi; Seyedeh Batool Hasanpoor-Azghady; Leila Amiri-Farahani; Imaneh Khaki
Journal:  Trials       Date:  2021-09-26       Impact factor: 2.279

Review 3.  The Application of Acupuncture Therapy for Postoperative Pain Over the Past 20 Years: A Bibliometric Analysis.

Authors:  Yilin Liu; Liuyang Huang; Guixing Xu; Hao Tian; Zhuo Zhou; Fengyuan Huang; Fanrong Liang
Journal:  J Pain Res       Date:  2022-07-27       Impact factor: 2.832

Review 4.  Efficacy of auricular therapy for pain management: a systematic review and meta-analysis.

Authors:  Chao Hsing Yeh; Yi Chien Chiang; Samuel L Hoffman; Zhan Liang; Mary Lou Klem; Wilson W S Tam; Lung-Chang Chien; Lorna Kwai-Ping Suen
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-23       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.